# Orthofix Medical Inc. (OFIX)

Source: https://www.quantisnow.com/company/OFIX
Generated: 2026-11-08T22:18:55.425Z

- Ticker: OFIX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical/Dental Instruments
- IPO year: 1992
- SEC CIK: 0000884624
- Website: orthofix.com

## About

Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Extremities. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The Global Extremities segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.

## Latest OFIX news and filings

- 2026-11-04 21:04 UTC [SEC Form 4] [President, Global Limb Recon Fisher Patrick sold $1,360 worth of shares (150 units at $9.07) as part of a pre-agreed trading plan, decreasing direct ownership by 0.29% to 50,769 units (SEC Form 4)](https://www.quantisnow.com/insight/president-global-limb-recon-fisher-patrick-sold-1360-worth-of-6772249)
- 2026-10-23 20:00 UTC [Earnings Date] [Orthofix to Report Third Quarter 2026 Financial Results](https://www.quantisnow.com/insight/orthofix-to-report-third-quarter-2026-financial-results-6756211)
- 2026-10-05 20:20 UTC [SEC Form 4] [President, Global Limb Recon Fisher Patrick sold $1,416 worth of shares (150 units at $9.44) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/president-global-limb-recon-fisher-patrick-sold-1416-worth-of-6736992)
- 2026-09-23 19:52 UTC [Insider Buy] [Amendment: Large owner Juniper Investment Company, Llc bought $2,732,097 worth of shares (310,000 units at $8.81) (SEC Form 4)](https://www.quantisnow.com/insight/amendment-large-owner-juniper-investment-company-llc-bought-2732097-worth-6724081)
- 2026-09-22 20:26 UTC [SEC Form 4] [SEC Form 4 filed by Large owner Juniper Investment Company, Llc](https://www.quantisnow.com/insight/sec-form-4-filed-by-large-owner-juniper-investment-company-6723091)
- 2026-09-03 20:41 UTC [SEC Form 4] [President, Global Limb Recon Fisher Patrick sold $1,408 worth of shares (150 units at $9.39) as part of a pre-agreed trading plan, decreasing direct ownership by 0.29% to 51,069 units (SEC Form 4)](https://www.quantisnow.com/insight/president-global-limb-recon-fisher-patrick-sold-1408-worth-of-6705464)
- 2026-08-20 21:03 UTC [SEC Form 4] [President, Global Limb Recon Fisher Patrick sold $13,067 worth of shares (1,295 units at $10.09), decreasing direct ownership by 2% to 51,219 units (SEC Form 4) (for withholding tax)](https://www.quantisnow.com/insight/president-global-limb-recon-fisher-patrick-sold-13067-worth-of-6690377)
- 2026-08-18 21:05 UTC [SEC Form 4] [SEC Form 4 filed by Large owner Juniper Investment Company, Llc](https://www.quantisnow.com/insight/sec-form-4-filed-by-large-owner-juniper-investment-company-6687082)
- 2026-08-05 20:07 UTC [SEC Form S-8] [SEC Form S-8 filed by Orthofix Medical Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-orthofix-medical-inc-6665125)
- 2026-08-05 11:06 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Orthofix Medical Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-orthofix-medical-inc-6663904)
- 2026-08-05 11:03 UTC [SEC Form 8-K] [Orthofix Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/orthofix-medical-inc-filed-sec-form-8-k-results-of-operations-6663887)
- 2026-08-05 11:00 UTC [Earnings Date] [Orthofix Reports Second Quarter 2026 Results Reflecting Continued Operational Progress](https://www.quantisnow.com/insight/orthofix-reports-second-quarter-2026-results-reflecting-continued-operational-progress-6663820)
- 2026-07-21 13:00 UTC [Leadership Update] [MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth](https://www.quantisnow.com/insight/medtech-pioneer-max-reinhardt-joins-exex-to-drive-canopus-platform-6643474)
- 2026-07-20 11:00 UTC [Conference Announcement] [Orthofix to Participate in Upcoming Investor Conferences](https://www.quantisnow.com/insight/orthofix-to-participate-in-upcoming-investor-conferences-6641806)
- 2026-07-15 11:00 UTC [Earnings Date] [Orthofix to Report Second Quarter 2026 Financial Results](https://www.quantisnow.com/insight/orthofix-to-report-second-quarter-2026-financial-results-6637499)
- 2026-07-02 20:00 UTC [SEC Form 8-K] [Orthofix Medical Inc. filed SEC Form 8-K: Regulation FD Disclosure](https://www.quantisnow.com/insight/orthofix-medical-inc-filed-sec-form-8-k-regulation-fd-disclosure-6624993)
- 2026-06-22 20:14 UTC [SEC Form 4] [Pres, Global Ops & Qual Mcpherron Aviva sold $34,425 worth of shares (3,670 units at $9.38), decreasing direct ownership by 5% to 66,330 units (SEC Form 4) to cover withholding tax](https://www.quantisnow.com/insight/pres-global-ops-qual-mcpherron-aviva-sold-34425-worth-of-6610785)
- 2026-06-12 22:31 UTC [SEC Form 4] [Director Bazaar Alan Lee was granted 14,965 shares, increasing direct ownership by 30% to 65,489 units (SEC Form 4)](https://www.quantisnow.com/insight/director-bazaar-alan-lee-was-granted-14965-shares-increasing-direct-6601368)
- 2026-06-12 22:30 UTC [SEC Form 4] [Director Kummeth Charles R. was granted 14,965 shares, increasing direct ownership by 24% to 76,305 units (SEC Form 4)](https://www.quantisnow.com/insight/director-kummeth-charles-r-was-granted-14965-shares-increasing-direct-6601365)
- 2026-06-12 22:29 UTC [SEC Form 4] [Director Hannon Jason was granted 14,965 shares, increasing direct ownership by 21% to 87,662 units (SEC Form 4)](https://www.quantisnow.com/insight/director-hannon-jason-was-granted-14965-shares-increasing-direct-ownership-6601363)
- 2026-06-12 22:28 UTC [SEC Form 4] [Director Finegan Michael was granted 20,721 shares, increasing direct ownership by 34% to 81,617 units (SEC Form 4)](https://www.quantisnow.com/insight/director-finegan-michael-was-granted-20721-shares-increasing-direct-ownership-6601361)
- 2026-06-12 22:28 UTC [SEC Form 4] [Director Capps Vickie L was granted 14,965 shares, increasing direct ownership by 53% to 43,300 units (SEC Form 4)](https://www.quantisnow.com/insight/director-capps-vickie-l-was-granted-14965-shares-increasing-direct-6601360)
- 2026-06-12 22:27 UTC [SEC Form 4] [Director Henneman John B Iii was granted 14,965 shares, increasing direct ownership by 16% to 105,774 units (SEC Form 4)](https://www.quantisnow.com/insight/director-henneman-john-b-iii-was-granted-14965-shares-increasing-6601359)
- 2026-06-12 22:26 UTC [SEC Form 4] [Director Burris Wayne was granted 14,965 shares, increasing direct ownership by 30% to 65,504 units (SEC Form 4)](https://www.quantisnow.com/insight/director-burris-wayne-was-granted-14965-shares-increasing-direct-ownership-6601357)
- 2026-06-12 22:25 UTC [SEC Form 4] [Director Maniar Shweta was granted 14,965 shares, increasing direct ownership by 28% to 69,038 units (SEC Form 4)](https://www.quantisnow.com/insight/director-maniar-shweta-was-granted-14965-shares-increasing-direct-ownership-6601356)
- 2026-06-12 22:24 UTC [SEC Form 4] [Director Paolucci Michael E was granted 14,965 shares, increasing direct ownership by 17% to 102,727 units (SEC Form 4)](https://www.quantisnow.com/insight/director-paolucci-michael-e-was-granted-14965-shares-increasing-direct-6601355)
- 2026-06-11 11:01 UTC [SEC Form 8-K] [Orthofix Medical Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/orthofix-medical-inc-filed-sec-form-8-k-leadership-update-submission-6598134)
- 2026-05-29 20:57 UTC [SEC Form 4] [SEC Form 4 filed by Large owner Juniper Investment Company, Llc](https://www.quantisnow.com/insight/sec-form-4-filed-by-large-owner-juniper-investment-company-6579716)
- 2026-05-29 18:59 UTC [SEC Form 3] [New insider Juniper Investment Company, Llc claimed ownership of 4,200,543 shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-juniper-investment-company-llc-claimed-ownership-of-4200543-6578847)
- 2026-05-29 14:13 UTC [SEC Form SD filed by Orthofix Medical Inc.](https://www.quantisnow.com/insight/sec-form-sd-filed-by-orthofix-medical-inc-6578635)
- 2026-05-21 12:00 UTC [SEC Form 8-K] [Orthofix Medical Inc. filed SEC Form 8-K: Regulation FD Disclosure](https://www.quantisnow.com/insight/orthofix-medical-inc-filed-sec-form-8-k-regulation-fd-disclosure-6566458)
- 2026-05-18 11:00 UTC [Conference Announcement] [Orthofix to Participate in Upcoming Investor Conferences](https://www.quantisnow.com/insight/orthofix-to-participate-in-upcoming-investor-conferences-6559008)
- 2026-05-08 20:52 UTC [Insider Buy] [Director Henneman John B Iii bought $61,295 worth of shares (5,000 units at $12.26), increasing direct ownership by 6% to 90,809 units (SEC Form 4)](https://www.quantisnow.com/insight/director-henneman-john-b-iii-bought-61295-worth-of-shares-6542739)
- 2026-05-07 22:15 UTC [Insider Buy] [Large owner Engine Capital Management, Lp bought $2,232,927 worth of shares (184,896 units at $12.08) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-engine-capital-management-lp-bought-2232927-worth-of-6540486)
- 2026-05-06 11:00 UTC [Orthofix Expands Pediatric Limb Reconstruction Portfolio with New FITBONE™ Innovation at POSNA 2026 Annual Meeting](https://www.quantisnow.com/insight/orthofix-expands-pediatric-limb-reconstruction-portfolio-with-new-fitbone-innovation-6533875)
- 2026-05-05 11:03 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Orthofix Medical Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-orthofix-medical-inc-6530696)
- 2026-05-05 11:02 UTC [SEC Form 8-K] [Orthofix Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/orthofix-medical-inc-filed-sec-form-8-k-results-of-operations-6530679)
- 2026-05-05 11:00 UTC [Earnings Date] [Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year 2026 Financial Guidance](https://www.quantisnow.com/insight/orthofix-reports-first-quarter-2026-results-highlighting-steady-execution-following-6530611)
- 2026-04-29 20:27 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Orthofix Medical Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-orthofix-medical-inc-6521560)
- 2026-04-29 20:20 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Orthofix Medical Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-orthofix-medical-inc-6521518)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/OFIX
- Earnings history: https://www.quantisnow.com/earnings/OFIX
- Dividend history: https://www.quantisnow.com/dividends/OFIX
- Insider transactions: https://www.quantisnow.com/insiders/OFIX
- Options chain: https://www.quantisnow.com/options/OFIX
- SEC 8-K filings only: https://www.quantisnow.com/company/OFIX/8-k
- RSS and alerts for OFIX: https://www.quantisnow.com/docs/rss-feeds.md